ANIX (Anixa Biosciences) OCF Yield %: -7.94 (As of Jun. 26, 2026)


ANIX Anixa Biosciences Inc ANIX
27 GF Score
Price $2.64
! 3 Warning Signs
View Full Analysis

What is Anixa Biosciences OCF Yield %?

Anixa Biosciences ANIX -2.60% 27 OCF Yield % is -7.94 as of Jun. 26, 2026. GuruFocus rates ANIX with a GF Score™ of 27/100. The stock has 3 warning signs investors should review. Among 1,419 Biotechnology companies, Anixa Biosciences ranks better than 50.81% on this metric.

OCF Yield % is calculated as Cash Flow from Operations divided by Market Capitalization. It is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.

As of today, Anixa Biosciences's Trailing 12-Month Cash Flow from Operations is $-7.12 Mil, and Market Cap is $89.65 Mil. Therefore, Anixa Biosciences's OCF Yield % for today is -7.94%.

The historical rank and industry rank for Anixa Biosciences's OCF Yield % or its related term are showing as below:

ANIX' s OCF Yield % Range Over the Past 10 Years
Min: -45.87   Med: -6.39   Max: -2.75
Current: -7.94


During the past 13 years, the highest OCF Yield % of Anixa Biosciences was -2.75%. The lowest was -45.87%. And the median was -6.39%.

ANIX's OCF Yield % is ranked better than
50.81% of 1419 companies
in the Biotechnology industry
Industry Median: -8.48 vs ANIX: -7.94

Anixa Biosciences's OCF Margin % for the quarter that ended in Apr. 2026 was %.


Anixa Biosciences OCF Yield % Explanation

Similar to Earnings Yield %, OCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high operating cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.


Anixa Biosciences OCF Yield % Related Terms


Anixa Biosciences OCF Yield % Historical Data

* Premium members only.

The historical data trend for Anixa Biosciences's OCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Anixa Biosciences OCF Yield % Chart

Anixa Biosciences Annual Data
Trend Oct16 Oct17 Oct18 Oct19 Oct20 Oct21 Oct22 Oct23 Oct24 Oct25
OCF Yield %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -3.44 -3.75 -6.31 -6.51 -5.26

Anixa Biosciences Quarterly Data
Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25 Jan26 Apr26
OCF Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -6.69 -6.02 -3.68 -10.26 -6.84

ANIX vs PYPD, LONA, SGMO: OCF Yield % Comparison

For the Biotechnology subindustry, Anixa Biosciences's OCF Yield %, along with its competitors' market caps and OCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Anixa Biosciences OCF Yield % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Anixa Biosciences's OCF Yield % distribution charts can be found below:

* The bar in red indicates where Anixa Biosciences's OCF Yield % falls into.


ANIX
27GF Score
Anixa Biosciences Inc ANIX
OCF Yield % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Anixa Biosciences OCF Yield % Calculation

OCF Yield % is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.

Anixa Biosciences's OCF Yield % for the fiscal year that ended in Oct. 2025 is calculated as

OCF Yield %=Cash Flow from Operations / Market Cap
=-7.173 / 136.34782
=-5.26%

Anixa Biosciences's annualized OCF Yield % for the quarter that ended in Apr. 2026 is calculated as

OCF Yield %=Cash Flow from Operations * Annualized Factor / Market Cap
=-1.741 * 4 / 101.769
=-6.84%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Yield % →
What does a OCF Yield % of -7.94 mean?
Anixa Biosciences (ANIX) has a OCF Yield % of -7.94 as of Jun. 26, 2026. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Anixa Biosciences and its competitors. According to the industry distribution chart, Anixa Biosciences ranks #698 out of 1419 companies in the Biotechnology industry, placing it in the top 49.2%.
Is Anixa Biosciences' OCF Yield % too high?
Anixa Biosciences' current OCF Yield % is -7.94. Based on the distribution chart, Anixa Biosciences ranks #698 out of 1419 companies in the Biotechnology industry, which is above the industry midpoint. Overall, Anixa Biosciences has a GF Score™ of 27/100, reflecting its overall financial health beyond just this single metric.
How does Anixa Biosciences' OCF Yield % compare to PYPD and LONA?
According to the Biotechnology industry distribution chart, Anixa Biosciences ranks #698 out of 1419 companies for OCF Yield %. This puts Anixa Biosciences in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Yield % for a Biotechnology company?
A good OCF Yield % depends on the Biotechnology industry context. However, OCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Yield % mean?
A high OCF Yield % can signal that a stock is expensive relative to its fundamentals. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Anixa Biosciences and its competitors. Anixa Biosciences's current OCF Yield % is -7.94. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Anixa Biosciences stock overvalued right now?
Anixa Biosciences (ANIX) has a current OCF Yield % of -7.94. The current OCF Yield % is -7.94. Anixa Biosciences' overall GF Score™ is 27/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Yield % calculated?
OCF Yield % is calculated from a company's financial statements. For Anixa Biosciences (ANIX), the current OCF Yield % is -7.94 as of Jun. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Anixa Biosciences Business Description

Other Exchanges CY71:Germany
Address 3150 Almaden Expressway, Suite 250, San Jose, CA, USA, 95118
Anixa Biosciences Inc is a biotechnology company developing therapies and vaccines focused on critical unmet needs in oncology. Its operations are organized into reportable segments comprising Cancer Vaccines, CAR-T Therapies, and Other. The Cancer Vaccines segment involves vaccines to treat and prevent breast and ovarian cancer, as well as additional cancer vaccines targeting intractable cancers, including high-incidence malignancies in lung, colon, and prostate. The CAR-T Therapies segment involves the development of liraltagene autoleucel (lira-cel), an ovarian cancer immunotherapy using chimeric endocrine receptor-T cell technology, developed at its subsidiary, Certainty Therapeutics, Inc. The Other segment consists of legacy operations, including limited patent licensing activities.
27GF Score

Get the complete analysis for ANIX

OCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$2.64
Price